Skip to main content
Premium Trial:

Request an Annual Quote

China Medical Technologies Receives SFDA Approval for HPV Chip

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – China Medical Technologies said today it has received approval of its surface plasmon resonance-based HPV-DNA chip from the State Food and Drug Administration of China.

The chip can detect high-risk and low-risk genotypes by analyzing a patient sample on the company's fully automated SPR analyzer, Beijing-based China Medical Technologies said in a statement. It added that the chip can distinguish multiple human papillomavirus infections and determine the viral load.

According to the World Health Organization, China has about 500 million women ages 15 and up who are at risk for cervical cancer, the company said.